- EMA Starts New Review of Risks with High-strength Estradiol-containing Creams
- FDA Grants Accelerated Approval to Erdafitinib for Metastatic Urothelial Carcinoma
- FDA Expands Pembrolizumab Indication for First-line Treatment of NSCLC (TPS ≥1%)
- First-line Durvalumab Improves Survival Compared to Chemotherapy in Metastatic NSCLC
- Maintenance immunotherapy fails to improve survival in extensive small cell lung cancer [ELCC Press Release]
- PROs Were Consistent with the ITT Population Across PD-L1 Subgroups in Patients with Stage III NSCLC Receiving Durvalumab or Placebo
Latest Videos
Dr Devinder Bansi, one of BMI Healthcare's leading consultant gastroenterologists talks about colorectal cancer screening at the BMI Healthcare Gastroenterology and Colorectal Surgery Conference 2014.
Dr Khadija Aljefri talks to ecancertv at the XV World Congress on Cancers of the Skin in Edinburgh, UK, about her research on biomarker "IMP3" which may make screening for squamous cell carcinoma of t...
Prof Henry Kitchener talks about his research into HPV testing in cervical screening in the Institute of Cancer Sciences at The University of Manchester.
The superDimension system is an advanced imaging tool that combines GPS-like technology with a catheter-based system and uses the patient's natural airways t.
we talk to Professor Carlos Caldas about the identification of breast cancer subtypes through molecular profiling, and the clinical implications for diagnosis and treatment.
Jules Sumkin, DO, discusses how 3-D guided breast biopsy is the latest in a series of advancements in the field of radiation oncology.
Dr. Patrick Kamath, a Consultant in Gastroenterology and Hepatology at Mayo Clinic in Rochester, MN, discusses his article appearing in the March 2013 issue of Mayo Clinic Proceedings alerting clinici...
(Visit: http://www.uctv.tv/) Judith M. Walsh, M.D. looks at the controversies in cancer screening. She examines the efficacy current screening techniques, instances of false positives, testing biases,...
Speakers:
Andrew Fish, Executive Director AdvaMedDx
Amalia Issa, PhD MPH, University of the Sciences, Chair of the Department of Health Policy and Public Health, Director of the Program in Personali...